Antoine Depaulis
Antoine Depaulis is an expert in Neurology at INSERM (France). As of October 2026, ScienceLeadR ranks Antoine Depaulis in the top 1% of experts worldwide for Seizures and Epilepsy. Antoine Depaulis has authored 185 publications, the most recent in 2025. SLR score: 561 (community average: 125). How the SLR is computed.
LeadR Profile
Neurology
Subspecialties:
Main Topics
Publications and Clinical Studies
Profile data updated on
Organizations
Career arc: 1983 - 2025
Number : 185
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Synchrotron-generated microbeams as a radiosurgical alternative for drug-resistant epilepsies: Proof of concept in a mouse model of mesiotemporal lobe epilepsy. PMID 41432569 — drug resistant epilepsy, radiotherapy, hippocampus, epilepsy, synchrotrons, pharmaceutical preparations, seizures, therapeutics | Epilepsia | 2025 | 0 |
| Comorbidities in the mouse model of temporal lobe epilepsy induced by intrahippocampal kainate. PMID 40673651 — hippocampus, comorbidity, epilepsy, eating, epilepsy, temporal lobe, sudden unexpected death in epilepsy, estrous cycle, food, memory, impulsive behavior, temporal lobe, attention deficit disorder with hyperactivity | Epilepsia | 2025 | 4 |
| An Update on Stiripentol Mechanisms of Action: A Narrative Review. PMID 38443647 — cytochrome p-450 enzyme system, anticonvulsants, drug therapy, seizures, diagnosis, therapeutics, dravet syndrome | Adv Ther | 2024 | 15 |
| Barrel cortex development lacks a key stage of hyperconnectivity from deep to superficial layers in a rat model of Absence Epilepsy. PMID 38244975 — neurons, seizures, electrophysiology, neurology, epilepsy, absence, absenteeism | Prog Neurobiol | 2024 | 0 |
| Innovative minimally invasive options to treat drug-resistant epilepsies. PMID 37798162 — risk, brain, pharmaceutical preparations, therapeutics, neurology, synchrotrons, drug resistant epilepsy | Rev Neurol (Paris) | 2023 | 1 |
LeadR Networks
Main global connection map